Viewing nowEvista Tablets 60 mg (Raloxifene Hydrochloride)
Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Alvogen Korea Co., Ltd.

MFDS item code 200108676 · Approved 2001.07.18 · Insurance code 652606820
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women.
Administer 60 mg of raloxifene hydrochloride orally once daily.
This medication may increase the risk of venous thromboembolism, which occurs when blood clots in the veins block blood vessels. If limited movement occurs while taking this medication, it should be stopped, and may be restarted once symptoms improve. Caution is required in patients with impaired liver function as the concentration of this medication may increase, and regular monitoring of liver function test results is necessary. Use is not recommended in premenopausal women. It should not be used for the prevention of cardiovascular diseases and should be administered cautiously in patients at risk of stroke. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication as it could be harmful to the fetus or infant. Patients with a history of thrombosis, liver disease, uterine bleeding, or endometrial cancer should avoid this medication. Patients with high triglycerides or impaired kidney function should use this medication carefully. During treatment, facial flushing, leg cramps, peripheral edema, and cold-like symptoms may occur. Some medications may interact with this medication, so patients should inform their healthcare provider of any other medications they are taking. This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and is not intended for men or children. Overdosage may cause symptoms such as dizziness or leg cramps, so caution should be exercised. Store out of reach of children and do not transfer to other containers for safety.
Vasodilation (flushing), deep vein thrombosis, pulmonary embolism, retinal vein thrombosis, superficial venous thrombophlebitis, leg cramps, cold symptoms, peripheral edema, decreased platelet count, elevated AST and/or ALT, cholelithiasis, thrombocytopenia, nausea, vomiting, abdominal pain, dyspepsia, increased blood pressure, migraine, headache, rash, breast symptoms (pain, swelling, tenderness), arterial thromboembolism, retinal vein occlusion, stroke, death related to deep vein thrombosis, facial flushing, vaginal bleeding, facial edema, heartburn, constipation, itching, palpitations, fever, weakness, sweating, myalgia, insomnia, perineal pain, weight gain, arthritis, rheumatism-like symptoms, pain, fatigue, tightness, chest tightness, skin lesions, anxiety, weight loss, seizures, dyspnea, visual disturbances, taste disturbances, leg cramps, ataxia, rash, diarrhea, tremor, increased ALP, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering and kept at room temperature between 15 to 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication.
White oval coated tablet
28 tablets/box
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRaloxifene Hydrochloride 60mg
Tablet · Prescription medication
Alvogen Korea Co., Ltd.

Raloxifene Hydrochloride Monohydrate 62.12mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Huons Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Ilsung IS Co., Ltd.

Raloxifene Hydrochloride 60mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Raloxifene Hydrochloride
Prescription medication
Searle Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.